retatrutide before bed VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Phase 3: 60% Achieved

Novel dual mechanism: GLP-1 receptor agonism + GIP receptor antagonism Extended half-life designed for once-monthly administration Phase 2 data demonstrated approximately 20% mean weight loss at 52 weeks, with no clear plateau observed after one year in the obesity cohort

Promotes healthy immune system function

Its important to recognize that these experiences vary, and that new or changing symptoms are always worth understandingnot ignoring

YesPlexusDx offers Compounded Tirzepatide Injection (a dual GLP-1/GIP agonist, is $289/mo month-to-month (or $249/mo on the 6-month plan)), Oral Semaglutide ($289/month), Oral Tirzepatide ($349/month), Microdose GLP-1 Protocol ($129/month), and GLP-Squared combinations for patients seeking alternatives

In this article, we break down the latest clinical data, explain how each therapy works, and help you determine which approach may align best with your goals